Navigation Links
ZYDUS enters female health care segment

Zydus Cadila Healthcare Limited, the Ahmedabad based pharmaceutical company has launched a revolutionary drug, Bonmax (raloxifene hydrochloride) consolidating its presence in the female healthcare segment. Bonmax is used in the prevention and treatment of postmenopausal osteoporosis (PMO). The drug comes as third generation drug which not only safe but can also be used for long term. //

PMO primarily occurs due to the deficiency of the oestrogen hormone during the menopausal period in a woman, which usually sets in between 45 to 55 years. In India, PMO affects at least one out of every three menopausal women. It is aptly termed a ‘silent killer,’ as 30 per cent of bone mass is already lost by the time it is detected. If not prevented osteoporosis leads to fractures, mainly of the hip, spine and wrists, and could disable women for life. This disease is characterised by loss of bone mass, thus making bones very fragile thereby increasing the risk of fractures.

Bonmax is a selective estrogen receptor modulator. It maximises bone mass thereby reducing the risk of breast cancer and decreases total and LDL cholesterol. Currently international trials are on to explore its use as a drug to prevent and treat breast cancer.

Bonmax comes to India with an international experience of around four years. There are more than 10 million users of the drug in the US alone. With life expectancy of women in India on the rise, a safe and efficacious therapy can play a critical role in ensuring a healthier and graceful post-menopausal life. The company is optimistic that within the first year of its launch the drug would capture atleast 10 per cent of the Rs. 50 crore postmenopausal drugs market.

Page: 1

Related medicine news :

1. RANBAXY - enters anti-AIDS segment
2. Medicis Pharmaceutical company enters pediatric market
3. Risk of allergy more to children staying in day care centers
4. Walk-In Health Centers Launched By The NHS For Commuters
5. Primary Care centers to provide out patient treatment
6. Free HIV Tests Brings Crowd to the Testing Centers
7. NACO to Introduce 400 Additional AIDS/HIV Screening Centers
8. NACO Inaugurates 37 Additional HIV Treatment Centers
9. Radiotherapy Centers in Scotland Undergo Inspection
10. Are call centers turning a deaf ear to potential acoustic shocks?
11. ‘For-profit Dialysis Centers’ in the Spotlight Over Anti-anemia Drug Overdoe
Post Your Comments:

(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
Breaking Medicine Technology: